首頁 > 市場調查報告書 > 材料/化學品

有機化合物

市場調查報告書

商品編碼

1797277

全球乙二胺四乙酸（EDTA）管市場

Ethylenediamine Tetraacetic Acid (EDTA) Tubes

出版日期: 2025年08月25日 | 出版商:

Global Industry Analysts, Inc. | 英文 371 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球乙二胺四乙酸 (EDTA) 管材市場規模將達到 29 億美元

全球乙二胺四乙酸 (EDTA) 管市場規模預計在 2024 年為 21 億美元，預計到 2030 年將達到 29 億美元，在 2024-2030 年的分析期內，複合年成長率為 5.5%。 K2 EDTA 管是本報告分析的細分市場之一，預計其複合年成長率為 4.4%，到分析期結束時市場規模將達到 17 億美元。 K3 EDTA 管細分市場在分析期間的複合年成長率預計為 7.3%。

美國市場規模估計為 5.757 億美元，中國市場預計複合年成長率為 8.5%

美國乙二胺四乙酸 (EDTA) 管材市場規模預計在 2024 年達到 5.757 億美元。預計到 2030 年，作為世界第二大經濟體的中國市場規模將達到 5.806 億美元，在 2024-2030 年的分析期內，複合年成長率為 8.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 2.8% 和 5.4%。在歐洲，預計德國的複合年成長率為 3.6%。

全球乙二胺四乙酸（EDTA）管市場－主要趨勢與促進因素摘要

為什麼 EDTA 管在現代診斷和臨床實驗室中被視為必不可少的？

乙二胺四乙酸 (EDTA) 管是常見的血液採集容器，預先塗上 EDTA 作為抗凝血劑。 EDTA 能有效結合鈣離子，防止血塊形成並維持血球形態，使其成為血液學檢測的必需品。 EDTA 管廣泛用於全血球計數 (CBC)、血型鑑定、分子診斷以及各種基於 DNA 和 RNA 的檢測。

血液學診斷的準確性和可靠性在很大程度上取決於所採集檢體的完整性。 EDTA 管在採集後數小時內可維持細胞結構，進而能準確分析白血球、紅血球、血小板和核酸。 EDTA 管廣泛應用於醫院、診斷實驗室、血庫和研究機構，是常規和專業實驗室工作流程中不可或缺的試劑。

EDTA 管有哪些新材料和設計改進？

製造商正在透過改進材料品質、封閉系統和抗凝劑配方來改進EDTA試管。大多數試管由玻璃或塑膠（聚對苯二甲酸乙二酯或聚丙烯）製成，塑膠因其易破損且重量輕而成為首選。創新技術包括螺旋蓋、安全蓋和真空密封設計，以確保無污染的採集和處理。

噴霧乾燥或液體EDTA的均勻塗層可確保一致的抗凝血效果。不同地區的瓶蓋顏色編碼（主要為淡紫色或紫色）已標準化，以便於實驗室快速識別。一些製造商採用條碼標籤、容量指示器和RFID晶片，以改善追蹤和樣本處理。凝膠分離劑和凝血活化劑等添加劑也正在考慮用於特定使用案例，以提高各種診斷的樣本品質。

需求將會在哪裡成長？核心最終用戶是誰？

由於診斷程序的增加以及慢性病和感染疾病負擔的加重，全球對 EDTA 採血管的需求正在不斷成長。核心使用者包括臨床實驗室、醫院、病理實驗室、血庫、生物庫和學術研究中心。預防性篩檢、個人化醫療和傳染病檢查的快速成長也增加了採血頻率，從而刺激了採血管的使用。

高使用率市場包括北美和歐洲，得益於先進的醫療基礎設施和自動化血液分析儀的常規使用。亞太地區正經歷強勁成長，這得益於診斷網路的擴展、都市區醫療保健服務的普及以及實驗室自動化投資的增加。在新興市場，政府的公共衛生診斷計畫正在推動標準化採血系統的採購增加。

是什麼推動了 EDTA 管市場的成長？

EDTA 管市場的成長受到多種因素的推動，包括全球診斷量的上升、對血液疾病篩檢的日益重視以及臨床實驗室的不斷擴張。血液採集系統的技術改進、與自動分析儀相容性的提高以及抗凝血劑穩定性的提升，正在增強該產品的相關性。

分子診斷、癌症基因組學和人口健康研究等領域的終端應用日益廣泛，這推動了對EDTA保存血液樣本的日益依賴。家用診斷和就地檢驗的興起也推動了攜帶式安全採血設備的創新。隨著醫療保健系統越來越以診斷為中心，實驗室自動化程度不斷提高，EDTA採血管很可能仍將是臨床樣本管理的重要組成部分。

部分

類型（K2 EDTA 管、K3 EDTA 管）、用途（全血球計數、血液抹片、血液凝固檢驗測試、骨髓切片檢查、其他）、最終用途（醫院最終用途、診斷中心最終用途、研發中心最終用途、其他最終用途）

受訪公司範例

AdvaCare Pharma
APT Medical
BD-Becton, Dickinson and Company
CDRICH
FL Medical srl
Gong Dong（Zhejiang Gongdong）
Greiner Bio-One AG（GBO）
Guangzhou Jiuan Medical Equipment Co. Ltd
Haemonetics Corp.
Hongyu Medical
Improve Medical
Medtronic PLC
Narang Medical Pvt Ltd
Sanli Medical
Sarstedt AG & Co.
Sekisui Diagnostics
Shanghai Biyun Medical Technology Co. Ltd
Terumo Corporation
TUD（Tianjin Union Development）
Vitrex Medical A/S

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Ethylenediamine Tetraacetic Acid (EDTA) Tubes estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. K2 EDTA Tube, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the K3 EDTA Tube segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$575.7 Million While China is Forecast to Grow at 8.5% CAGR

The Ethylenediamine Tetraacetic Acid (EDTA) Tubes market in the U.S. is estimated at US$575.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$580.6 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market - Key Trends & Drivers Summarized

Why Are EDTA Tubes Considered Essential in Modern Diagnostic and Clinical Laboratories?

Ethylenediamine tetraacetic acid (EDTA) tubes are commonly used blood collection containers pre-coated with EDTA as an anticoagulant. These tubes are critical for hematology tests because EDTA effectively binds calcium ions, preventing clot formation and preserving blood cell morphology. They are widely used for complete blood counts (CBC), blood typing, molecular diagnostics, and various DNA or RNA-based tests.

The precision and reliability of blood-based diagnostics heavily depend on the integrity of the collected specimen. EDTA tubes maintain cellular structure for hours after collection, enabling accurate analysis of white and red blood cells, platelets, and nucleic acids. Their widespread use across hospitals, diagnostic labs, blood banks, and research facilities makes them indispensable in routine and specialized laboratory workflows.

What Are the Emerging Material and Design Improvements in EDTA Tubes?

Manufacturers are refining EDTA tubes through improvements in material quality, closure systems, and anticoagulant formulations. Most tubes are made of glass or plastic (polyethylene terephthalate or polypropylene), with plastic variants gaining preference due to their reduced breakage risk and lighter weight. Innovations include screw caps, safety closures, and vacuum-sealed designs to ensure contamination-free collection and processing.

Uniform coating of spray-dried or liquid EDTA ensures consistent anticoagulant action. Color-coded caps, primarily lavender or purple, are standardized across regions to facilitate quick identification in labs. Some manufacturers are integrating barcode labels, volume indicators, and RFID chips for improved tracking and sample handling. Additions such as gel separators or clot activators are also being explored for specific use cases, enhancing sample quality across diverse diagnostics.

Where Is Demand Expanding, and Who Are the Core End-Users?

EDTA tube demand is expanding globally due to the increasing number of diagnostic procedures and the rising burden of chronic and infectious diseases. Core users include clinical laboratories, hospitals, pathology labs, blood banks, biobanks, and academic research centers. Rapid growth in preventive screening, personalized medicine, and infectious disease testing has also increased the frequency of blood draws, thereby fueling tube usage.

High-volume markets include North America and Europe, supported by advanced healthcare infrastructure and routine use of automated hematology analyzers. Asia Pacific is witnessing strong growth due to expanding diagnostic networks, urban healthcare access, and rising investments in laboratory automation. In emerging markets, government programs for public health diagnostics are contributing to increased procurement of standardized blood collection systems.

What Is Driving Growth in the EDTA Tubes Market?

Growth in the EDTA tubes market is driven by several factors including rising global diagnostic volumes, increased focus on blood-based disease screening, and the expanding reach of clinical laboratories. Technological improvements in blood collection systems, enhanced compatibility with automated analyzers, and better anticoagulant stability are reinforcing product relevance.

End-use expansion in molecular diagnostics, cancer genomics, and population health studies is increasing reliance on EDTA-preserved blood samples. Growth in home diagnostics and point-of-care testing is also supporting innovation in portable and safe blood collection devices. As healthcare delivery systems become more diagnostic-centered and lab automation increases, EDTA tubes will continue to be a foundational element of clinical sample management.

SCOPE OF STUDY:

The report analyzes the Ethylenediamine Tetraacetic Acid (EDTA) Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (K2 EDTA Tube, K3 EDTA Tube); Application (Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Diagnostics Centers End-Use, R&D Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AdvaCare Pharma
APT Medical
BD - Becton, Dickinson and Company
CDRICH
F.L. Medical srl
Gong Dong (Zhejiang Gongdong)
Greiner Bio-One AG (GBO)
Guangzhou Jiuan Medical Equipment Co. Ltd
Haemonetics Corp.
Hongyu Medical
Improve Medical
Medtronic PLC
Narang Medical Pvt Ltd
Sanli Medical
Sarstedt AG & Co.
Sekisui Diagnostics
Shanghai Biyun Medical Technology Co. Ltd
Terumo Corporation
TUD (Tianjin Union Development)
Vitrex Medical A/S

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Global Focus on Preventive Healthcare and Diagnostic Testing Drives Demand for EDTA Blood Collection Tubes
- Expansion of Clinical Laboratory Infrastructure in Emerging Markets Strengthens Market Penetration of EDTA Tubes
- Increasing Incidence of Infectious and Chronic Diseases Spurs Routine Use of EDTA Tubes in Hematological Testing
- Standardization of Blood Sample Collection Protocols in Hospitals Enhances Demand for Pre-Prepared EDTA Tubes
- OEM Innovation in Non-Glass, Shatterproof Tube Materials Supports Safety and Convenience in Sample Handling
- Regulatory Compliance for Blood Sample Preservation Drives Preference for EDTA Tubes in Plasma and CBC Testing
- Growth in Global Blood Donation and Transfusion Services Sustains Large-Scale Demand for EDTA Tubes in Blood Banks
- Automation in Diagnostic Laboratories Throws the Spotlight on EDTA Tubes with Robotic Compatibility and Barcode Labeling
- Increased Adoption of Vacuum Blood Collection Systems Enhances Efficiency and Reduces Contamination R
- Integration of EDTA Tubes in Point-of-Care Testing and Mobile Health Clinics Expands Access in Rural and Remote Settings
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for K2 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for K2 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for K2 EDTA Tube by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for K3 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for K3 EDTA Tube by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for K3 EDTA Tube by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for R&D Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for R&D Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for R&D Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Diagnostics Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Complete Blood Count Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Complete Blood Count Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Complete Blood Count Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Blood Smear Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Blood Smear Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Blood Smear Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Coagulation Tests Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Coagulation Tests Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Coagulation Tests Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Bone Marrow Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Bone Marrow Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Bone Marrow Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 38: USA Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 40: USA 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 43: USA 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 46: USA 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
CANADA
- TABLE 47: Canada Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 49: Canada 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 55: Canada 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
JAPAN
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 56: Japan Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 58: Japan 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 59: Japan Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 61: Japan 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 64: Japan 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
CHINA
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 65: China Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 67: China 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 68: China Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 70: China 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 73: China 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
EUROPE
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 74: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 82: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 85: Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
FRANCE
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 86: France Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 88: France 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 89: France Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 91: France 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 94: France 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
GERMANY
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 95: Germany Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 97: Germany 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 98: Germany Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 100: Germany 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 103: Germany 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
ITALY
- TABLE 104: Italy Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 106: Italy 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 107: Italy Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 109: Italy 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 112: Italy 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 113: UK Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 115: UK 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 116: UK Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 118: UK 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 121: UK 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
SPAIN
- TABLE 122: Spain Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 124: Spain 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 125: Spain Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 127: Spain 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 130: Spain 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 131: Russia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 133: Russia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 134: Russia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 136: Russia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 139: Russia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 142: Rest of Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 148: Rest of Europe 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
AUSTRALIA
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 161: Australia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 163: Australia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 164: Australia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 166: Australia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 169: Australia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
INDIA
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 170: India Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 172: India 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 173: India Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 175: India 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 178: India 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 181: South Korea 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 187: South Korea 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
LATIN AMERICA
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 199: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 208: Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 211: Argentina 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 217: Argentina 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 220: Brazil 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 226: Brazil 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
MEXICO
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 229: Mexico 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 235: Mexico 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
MIDDLE EAST
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 247: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 256: Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
IRAN
- TABLE 257: Iran Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 259: Iran 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 260: Iran Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 262: Iran 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 265: Iran 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 266: Israel Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 268: Israel 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 269: Israel Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 271: Israel 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 274: Israel 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 284: UAE Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 286: UAE 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 287: UAE Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 289: UAE 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 292: UAE 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030
AFRICA
- Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 302: Africa Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - K2 EDTA Tube and K3 EDTA Tube Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 304: Africa 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Type - Percentage Breakdown of Value Sales for K2 EDTA Tube and K3 EDTA Tube for the Years 2014, 2025 & 2030
- TABLE 305: Africa Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 307: Africa 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by End-Use - Percentage Breakdown of Value Sales for R&D Centers End-Use, Other End-Uses, Hospitals End-Use and Diagnostics Centers End-Use for the Years 2014, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 310: Africa 16-Year Perspective for Ethylenediamine Tetraacetic Acid (EDTA) Tubes by Application - Percentage Breakdown of Value Sales for Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

全球乙二胺四乙酸（EDTA）管市場

Ethylenediamine Tetraacetic Acid (EDTA) Tubes

受訪公司範例

目錄

第1章調查方法

第2章執行摘要

第3章市場分析

第4章競賽

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

全球乙二胺四乙酸（EDTA）管市場

Ethylenediamine Tetraacetic Acid (EDTA) Tubes

受訪公司範例

目錄

第1章調查方法

第2章執行摘要

第3章市場分析

第4章 競賽

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

第4章競賽